AzTrials
AzTrials

Endurance TrainingTRAILWISENCT07374016

Evaluation of a Training Recommendation Strategy for Trail Runners.

A study testing Training recommendations GEN, Training recommendations PERSO and Training recommendations PERSO-ADAPT in people with Endurance Training, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Finding the optimal training, i.e. the training that enables the athlete to achieve the best performance while preserving their physical and psychological integrity, is a multi-factorial issue. Each individual's background and training capacity are very different, hence the need for personalised training. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Endurance Training
What is being tested?
Training recommendations GEN, Training recommendations PERSO and Training recommendations PERSO-ADAPT
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,209 participants
Where
1 siteFrance
Study dates
Mar 2026to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Have no contraindications to trail running (Fédération Française d'Athlétisme test procedures)
  • Have been trail running competitively for at least 1 year
  • In possession of an ITRA performance index
  • Intends to run at least one ITRA-indexed race in the second half of the follow-up period
  • Own a training watch, and intend to record all training sessions of more than 10 minutes in their shared database
  • Have freely given their written consent.

Who cannot join

  • Any person with chronic joint pathologies (e.g. recurrent sprains, patellar or ligament problems) or cardiac pathologies.
  • Any person with chronic or central neurological pathologies.
  • Any person deprived of their liberty or under legal protection (guardianship, curatorship, safeguard of justice, family habilitation).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site
  • Unités de Myologie et de Médecine du Sport

    Saint-Etienne, France, 42055

    Léonard FEASSON, MD PhD, (0)4 77 12 03 83 ext. +33, leonard.feasson@chu-st-etienne.fr

    Diana RIMAUD, diana.rimaud@chu-st-etienne.fr

Other trials in France

About this study

Finding the optimal training, i.e. the training that enables the athlete to achieve the best performance while preserving their physical and psychological integrity, is a multi-factorial issue.

Each individual's background and training capacity are very different, hence the need for personalised training. The availability of data combined with advances in Artificial Intelligence (data modelling and analysis sciences, big data, machine learning, deep learning, etc.) offer the opportunity to refine our understanding of training and adapt recommendations according to the runner's profile for a given objective (achieving a time over a distance, completing an event, etc.). The strategy that the investigators wish to evaluate as part of this trial could make it possible to recommend an optimal training load, as well as the distribution of intensities (as a percentage of the aerobic threshold, anaerobic threshold, VVO2max, etc). The two features are (i) the personalisation will be based on training history, the level of the runner, age and gender, and the runner can focus on training, and (ii) the strategy will be adaptive, i.e. the algorithm will update the training load in real time based on contextual data about the athlete (level of fatigue via heart rate variability, feedback on recent training sessions, feelings of stress).

Being tested
Training recommendations GEN, Training recommendations PERSO, Training recommendations PERSO-ADAPT
Keywords
Trail running, Performance, Training recommendations, Artificial intelligence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Training recommendations GENProcedure or surgery

    Generic training plan that will be created from a platform that is both free and popular, offering training plans for trail-running (The Decathlon Pacer application).

  • Training recommendations PERSOProcedure or surgery

    A training plan that takes into account the rider's training history, in particular the number of hours per week over the last two years, the rider's level, age and gender, the time available for training and access to mountainous terrain.

  • Training recommendations PERSO-ADAPTProcedure or surgery

    A training plan that takes into account the rider's training history, in particular the number of hours per week over the last two years, the level, age and gender of the rider, the time available for training and access to mountainous terrain. Training will also be adapted on a weekly basis according to the following feedback: state of fatigue assessed by questionnaire and heart rate variability; state of overtraining, assessed by questionnaire; degree of completion of sessions.

Study groups in NCT07374016
Study groupRoleWhat they receive
GEN: generic training plan groupActive comparatorThe GEN group will follow a generic training plan that will be created from a platform that is both free and popular, offering training plans for trail-running (The Decathlon Pacer application).
Receives: Procedure: Training recommendations GEN
PERSO: non-adaptive personalized groupActive comparatorThe PERSO group will follow a plan that takes into consideration the training history, in particular the number of hours per week over the previous two years; the runner's level; age and sex; time available for training; and access to mountainous terrain.
Receives: Procedure: Training recommendations PERSO
PERSO-ADAPT group: adaptive personalized groupExperimentalThe PERSO-ADAPT group will include the same information as the PERSO group, but the training will also be adapted on a weekly basis according to the following feedback: state of fatigue assessed by questionnaire and heart rate variability; state of overtraining, assessed by questionnaire; degree of session completion).
Receives: Procedure: Training recommendations PERSO-ADAPT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of the ITRA performance index

    The main criterion for assessing the improvement in trail running performance will be the increase in the ITRA performance index of users following PERSO-ADAPT compared with the increase in the ITRA score of PERSO and GEN. The ITRA Performance Index (PI) is a tool that estimates a runner's level of performance. The performance index can be used to compare the level of different trail runners around the world and is built on a scale up to a maximum of 1000 points. The top of the scale corresponds to the theoretical best possible level.

    Measured: Month : 10

Secondary outcomes (6)
  1. Number of injuries

    The number of injuries will be assessed on the basis of weekly injury records, with injury defined as any physical pain or disability resulting from running that prevents running for at least one day.

    Measured: Weeks : 1 to 40

  2. ROF (Rating-of-Fatigue Scale)

    Fatigue will be assessed each week using the ROF (Rating-of-Fatigue Scale), validated in French. This scale from 0 to 10 with a pictogram gives an assessment that best reflects the perception of fatigue at that precise moment (from 0: not at all tired to 10: completely tired and exhausted).

    Measured: Weeks : 1 to 40

  3. RPE (Rating of Perceived Exertion)

    RPE (Rating of Perceived Exertion) will be assessed each week using the Borg scale and a visual analogue scale (VAS). It comprises 11 levels of perceived exertion, ranging from 0 (no exertion) to 10 (maximum exertion).

    Measured: Weeks : 1 to 40

  4. Hooper questionnaire

    Overtraining will also be assessed using the Hooper questionnaire. The higher the score, the more likely the athlete is to be in a state of physical or mental overload.

    Measured: Weeks : 1 to 40.

  5. The '36-12' field test

    Objective performance will be assessed by measuring critical speed, obtained using the '36-12' field test. This test, which can take the place of a training session, is carried out on a training track which is usual for the runner, and consists of: a run of 3600 metres, 30 minutes recovery time, then a run of 1200 metres. The time will be measured for each of the runs and the heart rate continuously recorded using the classic training heart rate monitor.

    Measured: Weeks : 6, 13, 20, 27, 34, 40.

  6. The 1200 test

    Objective performance will be assessed through changes in the duration of the 1200 test: after a 10-minute low-intensity warm-up, the participant will have to run 1200 m on a track at an intensity considered to be "low", recording his speed and heart rate at the same time using his watch.

    Measured: Weeks : 6, 13, 20, 27, 34, 40.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2026
  2. Study startMar 2026 (estimated)
  3. Primary completionAug 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Longitudinal, controlled, randomised, prospective study by downloading training data and questionnaires via smartphone.
Masking
None (open label)
Enrolment
1,209 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07374016
Sponsor's protocol ID
24CH251
Acronym
TRAILWISE
Status last verified
Jan 2026
First submitted
21 Jan 2026
Last updated
28 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Training recommendations GEN, Training recommendations PERSO and Training recommendations PERSO-ADAPT in people with Endurance Training, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Leonard FEASSON, MD PhD ((0)4 77 12 03 83 ext. +33, leonard.feasson@chu-saint-etienne.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of the ITRA performance index (time frame: Month : 10). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in